TW201235053A - Oral care product and methods of use and manufacture thereof - Google Patents
Oral care product and methods of use and manufacture thereof Download PDFInfo
- Publication number
- TW201235053A TW201235053A TW100141169A TW100141169A TW201235053A TW 201235053 A TW201235053 A TW 201235053A TW 100141169 A TW100141169 A TW 100141169A TW 100141169 A TW100141169 A TW 100141169A TW 201235053 A TW201235053 A TW 201235053A
- Authority
- TW
- Taiwan
- Prior art keywords
- mouthwash
- acid
- teeth
- reducing
- salt
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title description 3
- 239000002324 mouth wash Substances 0.000 claims abstract description 22
- 229940051866 mouthwash Drugs 0.000 claims abstract description 22
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000003755 preservative agent Substances 0.000 claims abstract description 17
- 230000002335 preservative effect Effects 0.000 claims abstract description 12
- 150000003751 zinc Chemical class 0.000 claims abstract description 11
- 239000007864 aqueous solution Substances 0.000 claims abstract description 4
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims abstract description 4
- -1 fluoride ions Chemical class 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 26
- 210000000214 mouth Anatomy 0.000 claims description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 16
- 230000036541 health Effects 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 11
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 235000011180 diphosphates Nutrition 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- 125000000129 anionic group Chemical group 0.000 claims description 7
- 230000006378 damage Effects 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims description 7
- 230000000813 microbial effect Effects 0.000 claims description 7
- 230000036996 cardiovascular health Effects 0.000 claims description 6
- 239000003906 humectant Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 206010020751 Hypersensitivity Diseases 0.000 claims description 5
- 208000027418 Wounds and injury Diseases 0.000 claims description 5
- 238000005115 demineralization Methods 0.000 claims description 5
- 230000002328 demineralizing effect Effects 0.000 claims description 5
- 210000003298 dental enamel Anatomy 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 206010013781 dry mouth Diseases 0.000 claims description 4
- 230000007406 plaque accumulation Effects 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 4
- 206010052428 Wound Diseases 0.000 claims description 3
- 208000026935 allergic disease Diseases 0.000 claims description 3
- 230000009610 hypersensitivity Effects 0.000 claims description 3
- 208000007565 gingivitis Diseases 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 229920005646 polycarboxylate Polymers 0.000 claims description 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 claims 2
- 230000000116 mitigating effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 112
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 abstract description 3
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002253 acid Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 229920001577 copolymer Polymers 0.000 description 12
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- 208000002925 dental caries Diseases 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 239000011775 sodium fluoride Substances 0.000 description 6
- 235000013024 sodium fluoride Nutrition 0.000 description 6
- 229960000414 sodium fluoride Drugs 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 5
- 230000000845 anti-microbial effect Effects 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 235000010356 sorbitol Nutrition 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229940091249 fluoride supplement Drugs 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 229920000515 polycarbonate Polymers 0.000 description 4
- 239000004417 polycarbonate Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 229910021653 sulphate ion Inorganic materials 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 3
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 3
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 3
- 230000003281 allosteric effect Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000002272 anti-calculus Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004673 fluoride salts Chemical class 0.000 description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 229950008882 polysorbate Drugs 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical group [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- AAWSDNAGOTWUPV-UHFFFAOYSA-N sulfanyloxyethene Chemical compound SOC=C AAWSDNAGOTWUPV-UHFFFAOYSA-N 0.000 description 3
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 3
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 229960003500 triclosan Drugs 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- RMUNKYMAGVBWDL-UHFFFAOYSA-N 3-sulfanylidene-1,2-thiazolidin-4-one Chemical compound SC1=NSCC1=O RMUNKYMAGVBWDL-UHFFFAOYSA-N 0.000 description 2
- ANAAMBRRWOGKGU-UHFFFAOYSA-M 4-ethyl-1-tetradecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+]1=CC=C(CC)C=C1 ANAAMBRRWOGKGU-UHFFFAOYSA-M 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OQQMLOABWOWXKW-UHFFFAOYSA-N C(C1=CC=CC=C1)(=O)OCCCCCCCCCCCC.[Na] Chemical compound C(C1=CC=CC=C1)(=O)OCCCCCCCCCCCC.[Na] OQQMLOABWOWXKW-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 108090000604 Hydrolases Proteins 0.000 description 2
- 102000004157 Hydrolases Human genes 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002882 anti-plaque Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 229960004217 benzyl alcohol Drugs 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- SAEOCANGOMBQSP-UHFFFAOYSA-N diazanium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [NH4+].[NH4+].[O-]P([O-])(F)=O SAEOCANGOMBQSP-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000004965 peroxy acids Chemical class 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001992 poloxamer 407 Polymers 0.000 description 2
- 229940044476 poloxamer 407 Drugs 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 2
- 229940082004 sodium laurate Drugs 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- MWNQXXOSWHCCOZ-UHFFFAOYSA-L sodium;oxido carbonate Chemical compound [Na+].[O-]OC([O-])=O MWNQXXOSWHCCOZ-UHFFFAOYSA-L 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JPJSDCXXUMJXLL-UHFFFAOYSA-N (1-hydroxy-3-sulfooxypropan-2-yl) hydrogen sulfate Chemical compound OS(=O)(=O)OC(CO)COS(O)(=O)=O JPJSDCXXUMJXLL-UHFFFAOYSA-N 0.000 description 1
- ILOOUJDIJNDKBD-UHFFFAOYSA-N (2,6-dimethyl-4-phenylheptan-4-yl)-dimethyl-(2-phenoxyethyl)azanium Chemical compound C=1C=CC=CC=1OCC[N+](C)(C)C(CC(C)C)(CC(C)C)C1=CC=CC=C1 ILOOUJDIJNDKBD-UHFFFAOYSA-N 0.000 description 1
- FEIQOMCWGDNMHM-KBXRYBNXSA-N (2e,4e)-5-phenylpenta-2,4-dienoic acid Chemical compound OC(=O)\C=C\C=C\C1=CC=CC=C1 FEIQOMCWGDNMHM-KBXRYBNXSA-N 0.000 description 1
- GYUKEMYHXWICKF-DKWTVANSSA-N (2s)-2-aminobutanedioic acid;calcium Chemical compound [Ca].OC(=O)[C@@H](N)CC(O)=O GYUKEMYHXWICKF-DKWTVANSSA-N 0.000 description 1
- ZINGPVGWKVTAAC-IAROGAJJSA-N (2z,4e)-2-chlorohexa-2,4-dienoic acid Chemical compound C\C=C\C=C(/Cl)C(O)=O ZINGPVGWKVTAAC-IAROGAJJSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- RWYRUDPAALLKPX-UHFFFAOYSA-N 2,2-difluoro-n-methylethanamine;hydrochloride Chemical compound Cl.CNCC(F)F RWYRUDPAALLKPX-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- RWMSXNCJNSILON-UHFFFAOYSA-N 2-[4-(2-propylpentyl)piperidin-1-yl]ethanol Chemical compound CCCC(CCC)CC1CCN(CCO)CC1 RWMSXNCJNSILON-UHFFFAOYSA-N 0.000 description 1
- FQHUWSPRTMWLFA-UHFFFAOYSA-N 2-cyclohexylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1CCCCC1 FQHUWSPRTMWLFA-UHFFFAOYSA-N 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
- UOWIFEANNONTKY-UHFFFAOYSA-N 2-hydroxy-5-octanoyl-n-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=C1 UOWIFEANNONTKY-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- ONPJWQSDZCGSQM-UHFFFAOYSA-N 2-phenylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1=CC=CC=C1 ONPJWQSDZCGSQM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KFGWEMFTDGCYSK-UHFFFAOYSA-N 3-methyl-1,2-thiazole 1-oxide Chemical compound CC=1C=CS(=O)N=1 KFGWEMFTDGCYSK-UHFFFAOYSA-N 0.000 description 1
- CYUZOYPRAQASLN-UHFFFAOYSA-N 3-prop-2-enoyloxypropanoic acid Chemical compound OC(=O)CCOC(=O)C=C CYUZOYPRAQASLN-UHFFFAOYSA-N 0.000 description 1
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 1
- QGHDLJAZIIFENW-UHFFFAOYSA-N 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxy-3-prop-2-enylphenyl)propan-2-yl]-2-prop-2-enylphenol Chemical group C1=C(CC=C)C(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C(CC=C)=C1 QGHDLJAZIIFENW-UHFFFAOYSA-N 0.000 description 1
- RJMWUGQXJQCTTH-UHFFFAOYSA-N 4-phenoxyisoindole-1,3-dione Chemical compound O=C1NC(=O)C2=C1C=CC=C2OC1=CC=CC=C1 RJMWUGQXJQCTTH-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- DSXDVJRPRNFODJ-UHFFFAOYSA-N C(CCCCCCCCC)C(CS(=O)(=O)O)C.C(C=C)N Chemical compound C(CCCCCCCCC)C(CS(=O)(=O)O)C.C(C=C)N DSXDVJRPRNFODJ-UHFFFAOYSA-N 0.000 description 1
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 description 1
- 239000001749 Calcium fumarate Substances 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- OJIYIVCMRYCWSE-UHFFFAOYSA-M Domiphen bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 OJIYIVCMRYCWSE-UHFFFAOYSA-M 0.000 description 1
- 206010013647 Drowning Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000209035 Ilex Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- VUXGHTWQWCWNCJ-UHFFFAOYSA-L S(=O)(=O)([O-])[O-].[Sr+2].[Na+] Chemical compound S(=O)(=O)([O-])[O-].[Sr+2].[Na+] VUXGHTWQWCWNCJ-UHFFFAOYSA-L 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 1
- 229950010221 alexidine Drugs 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940034055 calcium aspartate Drugs 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000004281 calcium formate Substances 0.000 description 1
- 235000019255 calcium formate Nutrition 0.000 description 1
- 229940044172 calcium formate Drugs 0.000 description 1
- 235000019296 calcium fumarate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- PWKNEBQRTUXXLT-ZBHRUSISSA-L calcium lactate gluconate Chemical compound [Ca+2].CC(O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O PWKNEBQRTUXXLT-ZBHRUSISSA-L 0.000 description 1
- 229940041131 calcium lactate gluconate Drugs 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000005588 carbonic acid salt group Chemical group 0.000 description 1
- NCBXYYPAHPNIJY-UHFFFAOYSA-N carbonic acid sulfuric acid Chemical compound S(=O)(=O)(O)O.S(=O)(=O)(O)O.C(O)(O)=O NCBXYYPAHPNIJY-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 150000001785 cerium compounds Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- GTBGXKPAKVYEKJ-UHFFFAOYSA-N decyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C(C)=C GTBGXKPAKVYEKJ-UHFFFAOYSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229960003854 delmopinol Drugs 0.000 description 1
- QSFOWAYMMZCQNF-UHFFFAOYSA-N delmopinol Chemical compound CCCC(CCC)CCCC1COCCN1CCO QSFOWAYMMZCQNF-UHFFFAOYSA-N 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229960001859 domiphen bromide Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- UQSQSQZYBQSBJZ-UHFFFAOYSA-M fluorosulfonate Chemical compound [O-]S(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-M 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- OGXRXFRHDCIXDS-UHFFFAOYSA-N methanol;propane-1,2,3-triol Chemical compound OC.OCC(O)CO OGXRXFRHDCIXDS-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WXUAQHNMJWJLTG-UHFFFAOYSA-N monomethylpersuccinic acid Natural products OC(=O)C(C)CC(O)=O WXUAQHNMJWJLTG-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229950002404 octapinol Drugs 0.000 description 1
- 229960001774 octenidine Drugs 0.000 description 1
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 150000002923 oximes Chemical group 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- MPNNOLHYOHFJKL-UHFFFAOYSA-K peroxyphosphate Chemical compound [O-]OP([O-])([O-])=O MPNNOLHYOHFJKL-UHFFFAOYSA-K 0.000 description 1
- FHHJDRFHHWUPDG-UHFFFAOYSA-L peroxysulfate(2-) Chemical compound [O-]OS([O-])(=O)=O FHHJDRFHHWUPDG-UHFFFAOYSA-L 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 229940044652 phenolsulfonate Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 description 1
- 229950000975 salicylanilide Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229940071182 stannate Drugs 0.000 description 1
- 125000005402 stannate group Chemical group 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- MDDUHVRJJAFRAU-YZNNVMRBSA-N tert-butyl-[(1r,3s,5z)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)-4-methylidenecyclohexyl]oxy-dimethylsilane Chemical group C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C(=C)\C1=C/CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MDDUHVRJJAFRAU-YZNNVMRBSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 230000036347 tooth sensitivity Effects 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 description 1
- YRQNNUGOBNRKKW-UHFFFAOYSA-K trifluororuthenium Chemical compound F[Ru](F)F YRQNNUGOBNRKKW-UHFFFAOYSA-K 0.000 description 1
- PHCPUBLHCIHBJG-UHFFFAOYSA-N trimethyl(sulfanyl)azanium Chemical compound C[N+](C)(C)S PHCPUBLHCIHBJG-UHFFFAOYSA-N 0.000 description 1
- WBGSMIRITKHZNA-UHFFFAOYSA-M trisodium;dioxido(oxidooxy)borane Chemical compound [Na+].[Na+].[Na+].[O-]OB([O-])[O-] WBGSMIRITKHZNA-UHFFFAOYSA-M 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- VSJRDSLPNMGNFG-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VSJRDSLPNMGNFG-UHFFFAOYSA-H 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 229940085658 zinc citrate trihydrate Drugs 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
201235053 六、發明說明: 【發明所屬之技術領域】 剛本發明關於一種漱口水,其包含可 鹽(例如,檸檬酸鋅)及選自曱基異嘆唾琳酮、笨甲醇 甘油單辛酸醋與其版合之保存劑,以及❹與 等組成物之方法。 °Λ 【先前技術】 [〇〇〇2]因為漱口水的高水含量,所以漱Π水在預 防微生物污染方面呈現特殊的挑戰。雖然已 1 有抗微生物活性-此確實為其在漱口水中的主 能,但疋其沒有對抗所有的微生 = 很重=辞離子可與調配物成分反應而升 == 性/儿瓜物或化學無效的錯合物時,則損害辞或保 或二者的有效性。另外 ^ 外一些保存劑對產品的味道或 、子、〜a。最後,慣用劑(諸如乙醇或對經義装 保存劑)可能不為特㈣適應症或特殊市忒 布里。 [0003]據此’有需要確則於包含鋅鹽 中的經改進之保存劑。 水 【發明内容】 現驚料發現包含可溶性鋅鹽及選自曱 二:丨:/ ?、苯甲醇、甘油單辛酸酯與其組合之保 存_漱口水是安定且有效的。辞鹽可為例如任何口、 201235053 腔可接受之可,谷性辞離子來源’例如擦樣酸辞。 [0005] 本發明因此包含口腔保健組成物及其使 用方法,其有效抑制或降低牙菌斑的累積,降低^酸 (致齲齒性)細菌的量,再礦質化牙齒及抑制或降低^ 齦炎。本發明亦包含清潔口腔之組成物及方法且提供 例如藉由降低經由口腔組織之全身性感染的可能性^ 促進口腔健康及/或全身健康(包括心血管健康)之改進 方法。 [0006] 本發明因此提供一種漱口水組成物(本發 明組成物)’其包含下列者之水性溶液: i.有效量的鋅鹽;及 11.有效量的保存劑,其係選自曱基異噻唑啉酮、苯曱 醇、甘油單辛酸酯與其組合。 [0007] 本發明組成物可包含額外的成分,例如選 自水、界面活性劑、溶劑、維生素、礦物質、聚合物、 酵素、保濕劑、增稠劑、額外的抗微生物劑、額外的 保存劑、調味劑、著色劑及/或其組合中之一或多者。 在特殊的具體例中’本發明可包含抗牙結石劑,例如 聚磷酸鹽,例如焦磷酸鹽、三聚磷酸鹽或六偏磷酸鹽, 例如呈驗金屬形式,例如納或卸鹽形式,及/或可包含 合成的陰離子聚合性聚羧酸鹽,諸如順丁烯二酸酐或 酸與另一可聚合之乙烯化不飽和單體的丨:4至4 : 1 共聚物,例如甲基乙烯醚/順丁烯二酸酐之共聚物。 [0008] 在本發明組成物中的單獨或組合之保存 201235053 劑的有效量為例如下列者:MIT :少於〇1% ,例如 0.0005-0.1〇/〇,例如 〇 〇〇1%,〇 〇1%或 〇 〇5% ;苯甲醇: 少於0.5%,例如〇·〇5_〇 25%,例如〇 1% ;或甘油單辛 酸醋:0.01%至0.25%。甘油單辛酸醋為取自Lexgard GMCY(Innolex Chemical)之具有甘油的辛酸單酯。曱 基異噻唑啉酮(MIT)及苯曱醇可從各種來源輕易取得。 [0009]本發明進一步包含在施予口腔時(例如,沖 洗口腔)有效使用組成物之方法,視需要與刷牙結合使 用,以(1)降低或抑制齲齒之形成,(ii)降低、修復或抑 制琺瑯質之齲前損傷,例如按定量性光-誘導螢光法 (QLF)或電鱗齒㈣量(ECM)所偵㈣,㈣降低或抑制牙 齒之去礦質化及促進牙齒之再礦質化,(iv)降低牙齒過 敏性’(v)降低或抑制牙齦炎,(vi)促進口中疼痛或傷 之疾癒,(VI1)降低產酸細菌之量,(viii)增加精胺酸 分解細菌之相對量,(ix)抑制口腔中的微生物性生物薄 膜之形成’(X)在糖需求之後,提高及/或維持牙菌斑 pH在至少pH 5.5之程度,(xi)降低牙菌斑累積㈣ …療 '減輕或降低口乾症,(xiii)清潔牙齒與口腔,㈣) 降低侵钱,(xv)潔自牙齒,(xvi)免疫牙齒免於致麟齒 細,,及/或(xvii)促進全身健康(包括心血管健康),例 如藉由降低經由口腔組織之全身性感染的可能性。 本發明的詳細說明 [0010]本發明因此在第一個具體例中提供一種 5 201235053 漱口水(組成物l.o),其包含下列者之水性溶液: i. 有效量的口腔可接受之可溶性鋅鹽量;及 ii. 有效量的保存劑,其係選自曱基異噻唑啉_(mit)、 本曱醇、甘油單辛酸醋與其組合。 例如’下列組成物中之任一者: 1.0. 1.組成物1.〇,其中鋅鹽為可溶性鋅離子的任何來 源,例如選自乙酸鹽、苯曱酸鹽、硼酸鹽、溴化 物、碳酸鹽、檸檬酸鹽、氯化物、甘油二酸=、 甘胺酸鹽、六氟>5夕酸鹽、dl-乳駿鹽(三水合物) 硝酸鹽、苯酚磺酸鹽、矽酸鹽、具有8_18個碳原 子之烷醇化物、水楊酸鹽、錫酸鹽、硫酸鹽灭、酉 石酸鹽、鈦酸鹽、四氟硼酸鹽、氧化物、 _ 物或氫氧化物。 ° _匕 1_0_2.前述組成物,其中鋅鹽為溶解之擰檬酸辞。 1.0. 3.前述組成物,其中鋅鹽為溶解之擰檬酸辞三 物。 1.0. 4.前述組成物中之任一者,其中鋅鹽係以從〇 至2重量%存在,例如0.1至1重量%。 1.0. 5.前述組成物中之任一者’其中保存劑係以如下 量存在: i. MIT :少於 0.1%,例如 0.0005-0.1%,例 0.00%,0.01%或 0.05% ; ii. 苯甲醇:少於0.5% ’例如〇·05_〇.25〇/〇,例如 0.1% ;及/或 201235053 iii.甘油單辛酸酯:0_01%至0.25%。 1.0. 6.前述組成物,其中保存劑為MIT。 1.0. 7.前述組成物中之任一者,其進一步包含抗牙結石 劑,例如聚磷酸鹽,例如焦磷酸鹽、三聚磷酸鹽 或六偏礙酸鹽,例如呈鹽形式,例如納或鉀鹽形 式,例如以從0.1-3%之量。 1.0. 8.前述組成物,其中抗牙結石劑為選自焦填酸四鈉 及焦磷酸四鉀與其混合物。 1.0. 9.前述組成物,其包含0.1至1%之焦磷酸四鈉及 1-2%之焦磷酸四鉀,例如0.25-0.75%之焦磷酸四 鈉及1.0-1.5%之焦磷酸四鉀。 1.0. 10.前述組成物中之任一者,其包含選自至少一種 下列的聚合物:聚乙二醇;合成的陰離子聚合性 聚碳酸酯,諸如聚乙烯基曱醚順丁烯二酸酸共聚 物;多糖(例如,纖維素衍生物,例如叛甲基纖維 素或多糖膠,例如黃原膠或鹿角菜膠);與其組合。 1.0. 11.前述組成物中之任一者,其包含合成的陰離子 聚合性聚碳酸自旨,例如以1 -10%之量,例如 2.5-7.5%。 1.0. 12.述組成物,其中合成的陰離子聚合性聚碳酸 酯為順丁烯二酸酐或酸與另一可聚合之乙烯化不 飽和單體的1:4至4:1之共聚物,例如具有30,000 至5,000,000道耳頓之分子量(M.W.)的曱基乙烯 醚/順丁烯二酸酐,例如1000kD-3000kD。 201235053 1.0. 13.前述組成物,其包含曱基乙烯醚/順丁烯二酸酐 之 共聚物 , 具 有通式 t~CH2-CH(OCH3)-CH(COOH)_CH(COOH)+n,在 25°C下具有l-3kCP之黏度,例如1.7xl03CP,及 1000kD-3000kD之標稱分子量,例如l.98xl〇6, 例如以1 -10重量%之量,例如5重量%。 1.0. 14.述組成物中之任一者,其不含乙醇。 1.0. 15.前述組成物中之任一者,其進一步包含呈游離 或鹽之鹼性胺基酸,例如精胺酸,例如以 重量%之量,例如0.8重量%。 1.0. 16.前述組成物中之任一者’其進一步包含可溶性 鈣鹽,例如選自甘油磷酸鈣及可溶性羧酸之鹽; 與其混合物’例如其中鈣鹽係選自檸檬酸鈣、多負 果酸鈣、乳酸鈣、甲酸鈣、反丁烯二酸鈣、葡萄 糖酸鈣、乳酸葡萄糖酸鈣、天冬胺酸鈣及丙酸約, 與其混合物。 1.0. 17.前述組成物中之任一者,其進一步包含氟化物 來源,例如氟化物鹽,例如氟化鈉,或其中氧化 物與另一原子共價結合,例如單氟構酸鹽,例如 單氟磷酸鈉’氟石夕酸鹽,例如氟梦酸納或氟石夕酸 銨,或氟硫酸鹽’例如六氟硫酸鹽,胺氟化物, 與其組合。 1.0·18.前述組成物,其中氟化物鹽係以提供1〇〇至250 ppm有效II化物之量存在。 201235053 1.0. 19.前述組成物中之任一者,其包含0.01-0.1%之量 的氟化納,例如0.05%。 1.0. 20.前述組成物中之任一者,其中pH係介於7與8 之間,例如7.5。 1.0. 21.前述組成物中之任一者,其進一步包含研磨料 或微粒。 1.0. 22.前述組成物中之任一者,其包含非離子性界面 活性劑,例如以從0.5-5%之量,例如1-2%,其係 選自泊洛沙姆(polaxamer)(例如,泊洛沙姆407)、 聚山梨酸酯(例如,聚山梨酸酯20)、聚氧氫化蓖 麻油(例如,聚氧40氫化蓖麻油),與其混合物。 1.0. 23.前述組成物中之任一者,其包含至少一種保濕 劑。 1.0. 24.前述組成物中之任一者,其包含至少一種選自 甘油、山梨醇、丙二醇與其組合之保濕劑,例如 以10-40%之總量。 1.0. 25.前述組成物中之任一者,其包含聚合物膜。 1.0. 26.前述組成物中之任一者,其包含調味劑、香料 及/或著色劑。 1.0. 27.前述組成物中之任一者,其包含至少50%之水。 1.0. 28.前述組成物中之任一者,其包含選自下列之抗 細菌劑:鹵化二苯醚(例如,三氯沙(triclosan))、 香草萃取物和精油(例如,迷迭香萃取物、茶萃取 物、木蘭萃取物、百里香酚、薄荷醇、桉葉醇、 201235053 香葉醇、香旱芹菜酚、擰檬醛、扁柏酚、兒茶酚、 水楊酸甲酯、表沒食子兒茶素沒食子酸酯、表沒 食子兒茶素、沒食子酸、蜜思瓦(miswak)萃取物、 沙棘萃取物)、雙胍(bisguanide)抗菌劑(例如,氣 己丁(chlorhexidine)、亞勒西丁(alexidine)或辛尼 丁(octenidine))、季銨化合物(例如,氯化錄蠛基吼 鍵:(CPC)、氯化苯二曱經敍(benzalkonium chloride)、氣化十四烧基β比旋(TPC)、氯化N-十四 烷基-4-乙基吡錠(TDEPC))、苯酚抗菌劑、己替丁 (hexetidine)、辛尼丁、jk 根驗、波維酮換(povidone iodine)、戴莫皮諾(delmopinol)、沙利氟 (salifluor)、其他的金屬離子(例如,錫鹽、銅鹽、 鐵鹽)、血根驗、普羅波理(propolis)及氧化劑(例 如,過氧化氫、緩衝之過氧硼酸鈉或過氧碳酸 納)、醜酸和其鹽、單過醜酸和其鹽與酯、硬脂酸 抗壞血酸酯、肌胺酸油醯酯、硫酸烷酯、磺基琥 ί白酸·一辛醋、水揚酿胺基苯(salicylanilide)、漠化 度明芬(domiphen bromide)、戴莫皮諾、辛太皮諾 (octapinol)和其他的哌啶衍生物、尼新(nicin)製 劑、次氣酸鹽與任何前述之混合物。 1.0.29前述組成物中之任一者,其包含抗氧化劑,例 如選自由辅酵素Ql〇、PQQ、維生素C、維生素E、 維生素A、BHT、茴香腦-二硫代硫酮 (anethole-dithiothione)與其混合物所組成之群組。 "U^35〇53 述組成物中之任—者,其包含潔白劑。 .月1j述組成物中之任一者,其包含選自由下列者 2組成之群_潔白劑:過氧化物、金屬次氯酸 二、過職鹽、過碳酸鹽、過氧酸、次氯酸鹽盘 其組合。 〃 3^、述組成物中之任一者,其進—步包含過氧化 乳或,氧化氫來源’例如過氧化尿素或過氧化物 義或複合物(例如,諸如過氧磷酸鹽、過氧碳酸 风過硼酸鹽、過氧矽酸鹽或過硫酸鹽;例如過 氧碟酸飼、過爾納、過氧化碳酸鈉、過氧鱗酸 =和過硫酸鉀),或過氧化氫聚合物複合物,諸如 過氧化氫-聚乙烯咣咯啶酮聚合物複合物。 ·0·33.前述組成物中之任一者,其進一步包含干擾或 阻止細菌附著之劑,例如ELA或幾丁聚糖。 lo’m.前述組成物中之任一者,其進一步包含生理上 可接又之鉀鹽,例如硝酸鉀或氣化鉀,以有效降 低牙齒敏感性之量。 1·〇·35.前述組成物中之任一者,其包含從〇 〇1%至1% 之生理上可接受之鉀鹽,例如;5肖酸鉀及/ 化 鉀。 …、 10.36.前述組成物中之任一者,在施予口腔時(例如, 乂冲洗)’視需要與刷牙結合,其有效(丨)降低或抑 =齲齒之形成,(H)降低、修復或抑制琺螂質之齲 則損傷,例如按定量性光-誘導螢光法(QLF)或電 201235053 =測里(ECM)所價測,(Hi)降低或抑制牙齒之去 礦質化及促進牙齒之再礦f化,(ιν)降低牙齒過敏 生’(V)降低或抑制牙酿炎,(vi)促進口中疼痛或 傷口之絲’(vii)降低產酸細菌之量,(νΗί)增加 精私酸刀解細菌之相對量,⑽抑制口腔中的微生 物性生物_之形成,⑴在糖需求之後,提高及 /或維持牙菌斑pH在至少pH 5 5之程度,⑽降 低牙菌斑累積,(χϋ)治療、減輕或降低口乾症,(xiii〕 清潔牙齒與口腔,(xiv)降低侵蝕,(χν)預防色斑 及/或潔白牙齒’(xvi)免疫牙齒免於致齲齒細菌, 及/或(xvii)促進全身健康(包括心血管健康),例如 藉由降低經由口腔組織之全身性感染的可能性。 1.0.37.—種藉由組合如在前述組成物中之任一者所提 出的成份而獲得或可獲得的組成物。 [0011]活性成份的量係以輸送系統及特定的活 性物為基礎而改變。例如,鋅鹽可以從例如0.05至2 重量%,例如0.1至1重量%之量存在。氟化合物可以 例如25至250 ppm或比專業或處方治療產品高至多 10倍之量存在。額外的抗細菌劑量同樣地取決於所使 用之劑而改變。例如,三氯沙漱口水可含有例如0.03 重量%之三氯沙。 [0012]在另一具體例中,本發明包含一種改進口 腔健康之方法,其包含將有效量的上述提出之具體例 中之任一者的組成物施予需要其之對象的口腔中,例
S 12 201235053 如此方法係: i_降低或抑制齲齒之形成,
1L . *法(QLF)或電齲齒測量(ECM)所偵 消’J, 化降低或抑fj牙齒之去礦質化及促進牙齒之再礦質 iv. 降低牙齒·過敏性, v. 降低或抑制牙齦炎, vi. 促進口中疼痛或傷口之痊癒, i抑制口腔中的微生物性生物薄膜之形成,
V1U.糖需求之後’提高及/或維持牙菌斑pH在至少pH 5.5之程度, ix.降低牙菌斑累積, χ· 治療口乾症, -提高全身健康(包括心血管健康),例如藉由降低 經由口腔組織之全身性感染的可能性, χϋ·潔白牙齒, xiii.降低牙齒的侵钱, X1v.免疫(或保護)牙齒免於致齲齒細菌,及/或 XV·清潔牙齒與口腔。 ▲ [0013]本發明進—步包含甲基異嗔哇仙、苯甲 醇、笨氧基乙醇與其組合在製造本發明組成物中之用 途,例如用於上述方法中所提出的適應症中之任一者。 13 201235053 _4]本發明組成物意欲於 ==鹽應就此用途、所提=濃; 受二=量包: Γ,上= 接所衍生之鹽,例如由形成生理上可 :::===成鹽,例如鹽酸鹽或 成 接f之陽離子的鹼所形 如那些從鹼金屬(諸㈣和納)或驗 土金屬㈣如㉝和鎂)所衍生者。生理上可接受的越可 使用本技藝中已知的標準程序而獲得,例如藉由將充 =:=如胺)與適合的酸反應’以供應生 [0015]氟化物離子來源:口腔保健組成物可進一 步包括4多種氟化物離子來源,例如可溶性氣化物 鹽。可將各種廣;乏的產生氟化物離子之材料用作為本 發明組成物巾的可溶性氣化物來源。適合的產生氟化 物離子之材料可見於Briner等人之美國專利第 3,535,421號;p_n,h等人之美國專利第4 885 155 號;Widder等人之美國專利第3,678,154號,併入本 文以供參考。代表性氟化物離子來源包括但不限於氟 化錫、氟化鈉、氟化鉀、單氟磷酸鈉、氟矽酸鈉、氟 石夕I錢、氟化胺、氟化録與其組合。在特定的具體例 中,氟化物離子來源包括氟化錫、氟化鈉、單氟磷酸 201235053 鈉與其混合物。在調配物包含鈣鹽時,氟化物鹽較佳 為其中氟化物與另一原子共價結合之鹽,例如在單氣 罐酸納中’而不是僅以離子結合之鹽,例如在氟化納 中。 界面活性劑 [0016]本發明可在一些具體例中含有陰離子性 界面活性劑,例如高碳脂肪酸單甘油酯單硫酸鹽之水 溶性鹽’諸如氫化椰子油脂肪酸之單硫酸化單甘油醋 之鈉鹽’諸如N-甲基N-椰油醯基牛續酸鈉、椰油_甘 油酯硫酸納,向碳烧基硫酸鹽’諸如月桂基硫酸納; 咼碳燒基-醚硫酸鹽,例如式 CH3(CH2)raCH2(OCH2CH2)n〇S03X,其中 m 為 6_16, 例如10,η為1-6,例如2、3或4,及X為Na或K, 例如月桂醚-2 硫酸鈉 (CH3(CH2)10CH2(〇CH2CH2)2〇S〇3Na);高碳烷基芳基 %I鹽,例如十二烷基苯確酸鈉(月桂基苯續酸鈉); 高,烧基績基乙㈣’諸如雜基職乙義(十二烧 基磺基乙S欠鈉)、1,2二羥基丙烷磺酸鹽之高碳脂肪酸 醋、續基椰子月桂酸鹽__乙基月桂酸鉀確基乙醯胺) 及月桂醯肌胺酸鈉。以1碳録,,意謂例如c63〇炫 ^。在特殊的具體例巾,陰離子性界面活性劑(在存在 4)係選自j桂基硫酸鈉及乙則桂基硫酸鈉。當存在 陰離子性界面活性劑係以有效的量存在,例如〉 調配物重1的〇._%,但不是會刺激口腔組織的濃 15 201235053 度,例如<ι%,而最優濃度係取決於特殊的調配及特 殊的界面活性劑。在一個具體例中,陰離子性界面活 性劑係以從0.03重量%至〇·5重量%存在,例如〇 15 重量%。 [0017] 在另一具體例中,可將本發明中有用的陽 離子性界面活性劑廣泛地定義為具有含有8至18個碳 原子之長鏈烧基的脂族季銨化合物之衍生物,諸如氣 化月桂基二m氣彳基d漠化録躐基三 曱基銨、氣化二異丁基苯氧基乙基二甲基苯甲基銨、 亞硝I椰子烧基二甲基録、氟化鯀犧基η比錠與其混合 物。例證之陽離子性界面活性劑為玢比打等人之美國 專利第3,535,421號中所述之氟化季錄,將其併入本文 以供參考。特定的陽離子性界面活性劑亦可充當為組 成物中的殺菌劑。 ' [0018] 可將本發明組成物中有用的例證之非離 子性界面活性劑廣泛地定義為藉由環氧烷基團(親水 性)與本質上可為脂族或烧基芳族之有機疏水性化合 物縮合而製得的化合物。適合的非離子性界面活性劑 之貫例包括但不限於Pluronics、烧基笨盼之聚環氧乙 烷縮合物、由環氧乙烷與環氧丙烷與乙烯二胺之反應 產物縮合所衍生之產物、脂族醇之環氧乙烷縮合物、 長鏈三級胺氧化物、長鏈三級氧化膦、長鏈二烷基亞 砜與該等材料之混合物。在特殊的具體例中,本發明 組成物包含非離子性界面活性劑,其係選自泊洛沙姆 201235053 (例如,泊洛沙姆407)、聚山梨酸酯(例如,聚山梨酸 醋20)、聚氧氫化蓖麻油(例如,聚氧4〇氫化蓖麻油) 與其混合物。 [0019] 在特定的具體例中,可將本發明組成物中 有用的合成之兩性離子界面活性劑廣泛地定義為脂族 季銨、鱗及錡化合物之衍生物,其中脂族基可為直鏈 或支鏈,且其中脂族取代基中之一含有8至18個碳原 子及一個含有陰離子性水-溶解基團,例如羧基、磺酸 基、硫酸基、磷酸基或膦酸基。 [0020] 適合包括於組成物中的例證之界面活性 劑的實例包括但不限於烷基硫酸鈉、月桂醯肌胺酸 鈉、椰子醯胺基丙基甜菜鹼及聚山梨酸酯2〇,與其組 合。 [0021] 界面活性劑或可相容之界面活性劑的混 合物可以佔總組成物重量的〇,1%至5%存在於本發明 的組成物中’在另一具體例中以〇.3%至,而^另 一具體例中以0.5%至2%。 調味劑 [0022] 本發明的口腔保健組成物亦可包括調味 劑。可在本發明的實施中使用的調味劑包括但不^於 精油及各種調味醛、酯、醇和類似材料,以及甜味二、 諸如糖精鈉。精油的實例包括綠薄荷、鴣^ ^ J /寻何、冬青樹、 黃樟、丁香、香紫蘇、桉樹、墨角籣、 m 月桂、檸檬、 菩提樹、葡萄柚及柳撥之油。亦有用者為諸如薄^ μ 17 201235053 香芹酮及茴香腦之化學品。特定的具體例使用薄荷及 綠薄荷之油。 [0023] 調味劑係以0.01至1重量%之濃度併入口 腔組成物中。 螯合劑及抗牙菌斑劑 [0024] 本發明的口腔保健組成物亦可視需要包 括一或多種能夠與細菌的細胞壁中發現的鈣錯合的螯 合劑。此妈的結合使細菌的細胞壁變弱且增加細菌溶 解。 [0025] —種適合用作為本發明中的螯合劑或抗 牙菌斑劑之群組為可溶性焦磷酸鹽。在本發明組成物 中使用的焦磷酸鹽可為鹼金屬焦磷酸鹽中之任一者。 在特定的具體例甲,該鹽包括四鹼金屬焦磷酸鹽、二 鹼金屬二酸焦磷酸鹽、三鹼金屬單酸焦磷酸鹽與其混 合物,其中鹼金屬為鈉或鉀。該等鹽類可以其水合及 未水合形式使用。在本發明組成物中有用的焦磷酸鹽 有效量通常足以提供至少約0.5重量%之焦磷酸鹽離 子,0.9-3重量%。 [0026] 該等化合物亦藉由降低水活性而有助於 組合物的保存。 聚合物 [0027] 本發明的口腔保健組成物亦可視需要包 括一或多種聚合物,諸如聚乙二醇、聚乙烯基甲醚順 丁稀二酸酸共聚物、多糖(例如,纖維素衍生物,例如
S 18 201235053 敌甲基纖維素或多糖膠,例如黃原膠、結冷膠或鹿角 菜膠)。酸性聚合物(例如’聚丙烯酸酯膠)可以其游離 酸或部分或完全中和之水溶性鹼金屬(例如’鉀和鈉) 或銨鹽形式提供。 [0028] 在特殊的具體例中,本發明組成物包括合 成的陰離子聚合性聚碳酸酯,諸如順丁烯二酸酐或酸 與另一可聚合之乙烯化不飽和單體的1 : 4至4 : 1共 聚物,較佳為曱基乙烯醚/順丁烯二酸酐之共聚物,具 有 30,000 至 3,000,000 之分子量(M.W.),最佳為 30,000 至800,000。該等共聚物可以例如Gantrez,例如AN 139(M.W. 500,000)、AN 119(M.W. 250,000)及 S-97 醫 藥級(M.W. 700,000至1,500,000)取得,該等係取自isP Technologies,Inc., Bound Brook, N.J. 08805 ° 當有增強 劑的存在時,其係以1至10重量%之量存在。 [0029] 其他起作用的聚合物包括那些諸如順丁 浠二酸針與丙烯酸乙醋、甲基丙稀酸經乙g旨、N-乙烯 基-2-吡咯啶酮或乙烯的1 : 1共聚物,後者可以例如
Monsanto EMA No. 1103,M.W. 10,000 及 EMA 等級 61,及丙烯酸與曱基丙烯酸曱酯或羥乙酯、丙稀酸曱 酉旨或乙醋、異丁基乙細基鍵或N-乙稀基-2-n比u各咬酿|的 1 : 1共聚物取得。 [0030] 通常適合者為含有活化之碳至碳婦煙雙 鍵及至少一個羧基的經聚合之烯烴化或乙埽化不飽和 羧酸,亦即含有可輕易在聚合反應中起作用之婦煙雙 19 201235053 鍵的酸,因為其存在於單體分子中相對於羧基的α_β 位置上或為末端亞曱基編組的一部分,例證之此等酸 為丙烯酸、甲基丙烯酸、乙基丙烯酸、α-氣丙烯酸、 巴豆酸、β-丙烯氧基丙酸、山梨酸、α-氯山梨酸、肉 桂酸、β-苯乙烯基丙烯酸、黏康酸、衣康酸、檸康酸、 中康酸、戊烯二酸、烏頭酸、α-苯基丙烯酸、2_笨甲 基丙烯酸、2-環己基丙烯酸、白芷酸、繳形酸、反丁 烯二酸、順丁烯二酸和酐。可與此等羧酸單體共聚合 之其他不同烯烴單體包括乙烯基乙酸酯、乙烯基氯、 順丁稀二酸二甲酯與類似物。共聚物含有足夠用於水 溶解之綾酸鹽基團。 [0031] 另一類別的聚合物劑包括含有經取代之 丙稀酿胺的均聚物及/或不飽和磺酸之均聚物與其鹽 之組成物’其中聚合物特別以不飽和磺酸為基礎,其 係選自丙烯醯胺烷磺酸,諸如具有MOO至2 〇〇〇,〇〇〇 之分子量的2-丙烯醯胺2曱基丙烷磺酸,說明於Zahid 於1989年6月27日之美國專利第4,842,847號中,併 文以供參考❶另一有用類別的聚合物劑包括聚胺 2 ’特別是那些含有成比例之陰料性表面活性胺 二^,諸如天冬胺酸、麩胺酸及磷絲胺酸,如在sikes ^ =美國專利第4,866,161中所揭示者,併入本文以 製備口腔保健組成物時,有時候必須添 到以提供所雜财料㈣ 配物 [0032] 加一些增祠 201235053 性能\在特定的具體例中,增稠劑為羧乙烯基聚合物、 角叉膠、羥乙基纖維素及纖維素醚之水溶性鹽,諸如 羧甲基纖維素鈉和羧甲基羥乙基纖維素鈉。亦可併入 天然膠,諸如刺捂桐膠、阿拉伯膠及黃蓍膠。凝態矽 酸鎂鋁或細碎的矽石亦可用作稠化組成物的成份,以 進一步改進組成物的質地。在特定的具體例中,使用 佔總組成物重量的0.5%至5%之量的增稠劑。 酵素 4,992,420 號 4,154,815 號 3,991,177 號 [0033]本發明的口腔保健組成物亦可視需要包 括一或多種酵素。有用的酵素包括任何可取得的蛋白 酶,葡萄糖水解酶、内切醣苷酶、澱粉酶、變構水解 酶、脂肪酶及黏蛋白酶或其可相容的混合物中之任一 者。在特定的具體财,酵素為蛋自酶,葡聚糖酶、 内切醣苷酶及變構水解酶。在另一具體例中,酵素為 木瓜酵素、内切醣苷酶或葡聚糖酶與變構水解酶之混 合物。其他適合於本發明使用之額外的酵素被揭示= Dring等人之美國專利第5,〇〇〇,939號,美國專利第 美國專利第4,355,022號;美國專利第 美國專利第4,058,595號;美國專利第 及美國專利第3,696,191號中,將全部 併入本文以供參考。在本發明中之數種可相容的酵素 之混合物中的酵素在一個具體例中構成〇 〇〇2%至 2.〇%,或在另-具體例中構成⑽抓至l s%,或在 又另一具體例中構成〇 1〇/〇至〇 5%。 21 201235053 水 [0034] 水係存在於本發明的口腔組成物中。在製 備市售口腔組成物所使用之水應去離子化且不含有機 雜質。水常用於補足組成物的差額且包括佔σ腔组成 物重量的10%至90%,例如40%至7〇%。此水^包括 所添加之自由水加上以其他材料(諸如山梨醇 發 明任何組份所引起的量。 — 保濕劑 [0035] 在口腔組成物之特定的具體例内亦希望 併入保濕劑’以降低蒸發作用及亦藉由降低水活性而 有助於保存。較的保關亦可賦歧成物所欲甜度 或氣味。以純保濕劑為基礎之保濕劑通常在一個具體 例中包括組成物重量的15%至7〇%,或在另一個具體 例中包括30%至65%。 [0036] 適合的保濕劑包括可食性多元經基醇,諸 如甘油、山梨醇、木糖醇、丙二醇以及其他多元醇, 與該等保關之混合與山梨醇之混合物可在 特定的具體例中用作為本文組成物的保濕劑組份。 [0037] 在本發明的方法觀點中本發明包含將安 全且有效量的本文所述之組成物施予口腔。 [0038] 根據本發明的組成物及方法有用於藉由 加速修復及再礦質化來防護牙齒之方法,特別藉由降 低或抑制麟齒之形成,降低或抑制牙齒之去礦質化及 促進牙齒之再鑛質化’降低牙齒過敏性,及降低、修
S 22 201235053 復或抑制早期的琺瑯質損傷,例如按定量性光-誘導螢 光去(QLF)或電齲齒監測器(ECM)所偵測。 [0〇39]用於本文所述之組成物的去敏化性質之 式驗方法係使用美國專利第5,589,159中所述之方 ,,將其揭示内容完整併入本文以供參考。此方法測 里材料的水力傳導,提供與牙本質小管中減少的流體 流動互相關聯之客觀減少的流體流動。在此方法中, 將沒有麴齒且重建的完整之人類臼齒以冶金鋸垂直於 牙齒長轴切片,形成從約〇.4至約〇·8毫米厚度的薄切 片’或圓片。選擇含有牙本質及沒有瑯質的切片用於 測試且接著以擰檬酸溶液浸潰,以移除污斑層。將每 個圓片架置在 j. Dent. Research,57:187 (1978)中所述 之分裂室裂置中,該農置有特殊的防漏室與含有組鐵 培養液的加壓之流體儲庫連接。藉由使用加壓氮與二 氧化碳氣體的混合物可使流體達到生理pH值。為了 進一步確保準確性,將圓片以人工唾液(磷酸鹽緩衝食 鹽水,PBS)弄濕,以接近於口腔内的條件。該設備包 括與流 1感測器(FLODEC,DeMarco Engineering SA, Geneva)連接的玻璃毛細管。將氣泡注入玻璃毛細管 中。精由測量以時間為函數的氣泡位移可測量通過斤 本質圓片的流體流動。流體流動相當於牙本質的滲透 性。 [0040]提高口腔健康亦提供使全身健康的好 處,因為口腔組織可為全身感染的入口。好的口腔健 23 201235053 康與全纽康有_ ’包括心血管健康。本發 成物及方法因此有用於提高全身健康。 [0041]按全文所使用之範圍係以縮寫使用 敘述在該各個和每—健。在域圍 何值均可被選擇為該範_界標1外,將本 述之所有參考文獻以其完整0容併人本文以供 在本發明中的定義與所料之參考文獻蚊義發生衝 突之情況巾,財㈣鱗。在敘_配物時,應二 解細f可就其成分而予以敘述,如本技藝中戶;常 見,儘官該等成分可在實際的調配物於製造、儲 =相反應,且此等產物意欲為所敘述之調配物 【實施方式】 =042]以下的實例進—步敘述且例證在本發明 的麟内之具關。實例僅提㈣於例證,並不料 限制,因為許多變化有可能不脫離其 精神與㈣。除了那些本文所顯示及所敘述者以外, 本發,的各種修改應為那些熟請本技藝者所明白且 意欲落在所附之申請專利範圍内。 實例1-漱口水 山梨醇(70%溶液) 甘油 [0043]本發明調配物係以下列成分製 原料 《 % . 10 10 24 201235053 丙二醇 7 檸檬酸鋅三水合物 0.28 Gantrez S-97(13%溶液) 1.92 焦磷酸鹽 1.7 氟化納 0.05 糖精鈉 0.025 界面活性劑 0.5 氣味 0.145 染料 0.0003 甲基異噻唑啉酮(MIT) 0.01 水 差額 總計 100 水活性 <95% pH 7.5 [0044] 為了使保存劑系統最優化,將甲基異噻唑 淋酮(MIT)在上述調配物中以各種保存劑取代,且以抗 微生物效力、氣味影響及美學影響测試調配物的特性。 [0045] 使用抗微生物保存有效性試驗測定以水 為底質之產品调配物的抗微生物保存有效性,其係利 用雙重挑戰試驗。開發之產品禁得起由正常的消費者 使用所引入之微生物挑戰。試驗係以老化之樣品進行 (13週,40°C)。試驗使用兩池微生物:細菌/酵母和徵 菌。產品係在第0天及第7天以1 %之量挑戰。經2 8 天期間監控減少的接種原。以下為漱口水調配物可接 25 201235053 受之標準。 -細菌及酵母必須在每個接種之後第7天顯示出減 少99.9%之細菌接種原(3 logs),如以盤中計數法所測 定。在第二次接種7天之後沒有增加且其餘的試驗係 在正常的數據偏差之内。 -黴菌必須在第二次接種之後第14天(21天)顯示 出減少90.0%之細菌接種原(1 log),如以盤中計數法所 測定。從試驗的第二次接種的14天至21天沒有增加, 在正常的數據偏差之内。 [0046] 氣味係經由訓練有素之調味師的感官性 能評估而予以評估。 [0047] 美學係由對具有相同類型及著色劑與調 味劑量的對照樣品之視覺比較而予以評估。 [0048]比較試驗的結果係如下,其中'W〃表示 符合標準,而〃表示不符合標準。
保存劑 笨曱 山梨 MIT 苯曱醇 苯氧基 聚醯亞胺 Legard/ 酸鈉 酸钟 乙醇 基雙胍 gmcy 微-勃性(Micro X X V V X X V robustness) 試管内效力 V V V V V V V 氣味影響 V V X 輕微 X X X 美學影響 V V V V V X X 該等結果顯示不同的保存劑系統在漱口水調配物
26 201235053 中有出乎意料的表現。提供可接受之微生物控制的最 合適之保存劑為單獨或組合的苯曱醇、曱基異噻唑啉 酮(MIT)及甘油單辛酸酯(Lexgard GMCY®)。曱基異噻 唑啉酮(MIT)對氣味的不利影響係藉由將量減少至 0.001%而降低,但是保留抗微生物效力。 27
Claims (1)
- 201235053 七、申請專利範圍: 1·一種漱口水,其包含下列之水性溶液: a. 有效量的口腔可接受之可溶性辞鹽;及 b. 有+效量的保存劑,其係選自曱基異噻唑啉酮(MIT)、 苯甲醇、甘油單辛酸酯與其組合。 2·根據申請專利範圍第1項之漱口水,i 鹽為檸檬酸辞。 3. 根據前述申請專利範圍中任一項之漱口水,其 中該鋅鹽係以對應於〇·〇5至2重量%之量存在。 4. 根據前述申請專利範圍中任一項之漱口水,其 中該保存劑係以如下的量單獨或組合存在: 八 a. MIT : 0.0005-03 重量 %, b. 苯曱醇:0.05-0.25重量%, c. 甘油單辛酸酯:〇 〇1%·〇 25重量%。 5. 根據前述申請專利範圍中任一項之漱口水,其 進一步包含焦磷酸鹽。 6. 根據前述申請專利範圍中任一項之漱口水,其 進一步包含合成的陰離子聚合性聚羧酸鹽。 7. 根據則述申請專利範圍中任一項之漱口水,其 進一步包含氟化物離子來源。 8·根據前述申請專利範圍中任一項之漱口水,其 不含乙醇。 9.根據前述申請專利範圍中任一項之漱口水,其 進一步包含保濕劑、調味劑及界面活性劑中之一或多 者028 201235053 1 〇.根據前述申請專利範圍中任一項之漱口水,其 中該保存劑包含有效提供微生物控制的量。 11.一種改進口腔健康之方法,其包含將有效量的 前述申請專利範圍中任一項之漱口水施予需要其之對 象的口腔中,以 a. 降低或抑制鱗齒之形成, b. 降低、修復或抑制早期的琺瑯質損傷, c. 降低或抑制牙齒之去礦質化及促進牙齒之再礦質 化, d. 降低牙齒過敏性, e. 降低或抑制牙齦炎, f. 促進口中疼痛或傷口之痊癒, g. 抑制口腔中的微生物性生物薄膜之形成, h. 糖需求之後,提高及/或維持牙菌斑pH在至少pH 5.5 之程度, i. 降低牙菌斑累積, j. 治療、減輕或降低口乾症, k. 潔白牙齒, l. 提高全身健康,包括心血管健康, m. 降低牙齒的侵姓, η.免疫牙齒免於致鑛齒細菌及其影響,及/或 〇.清潔牙齒與口腔。 29 201235053 四、指明代表圖: (一) 本案指明代表圖為:第(無)圖。 (二) 本代表圖之元件符號簡單說明: 無 五、本案若有化學式時,請揭示最能顯示發明特徵的化學 式:
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2010/056518 WO2012064341A1 (en) | 2010-11-12 | 2010-11-12 | Oral care product and methods of use and manufacture thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201235053A true TW201235053A (en) | 2012-09-01 |
TWI533889B TWI533889B (zh) | 2016-05-21 |
Family
ID=44560568
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103129282A TW201521772A (zh) | 2010-11-12 | 2011-11-11 | 口腔保健產品及其使用方法與製造 |
TW100141169A TWI533889B (zh) | 2010-11-12 | 2011-11-11 | 口腔保健產品及其使用方法與製造 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103129282A TW201521772A (zh) | 2010-11-12 | 2011-11-11 | 口腔保健產品及其使用方法與製造 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20130230469A1 (zh) |
EP (1) | EP2637633B1 (zh) |
JP (1) | JP2013540813A (zh) |
CN (3) | CN107252396A (zh) |
AR (1) | AR083864A1 (zh) |
AU (1) | AU2010363659B2 (zh) |
BR (1) | BR112013011562C8 (zh) |
CA (1) | CA2815640C (zh) |
MX (1) | MX338600B (zh) |
PH (1) | PH12013500721A1 (zh) |
RU (1) | RU2597159C2 (zh) |
SG (1) | SG189862A1 (zh) |
TW (2) | TW201521772A (zh) |
WO (1) | WO2012064341A1 (zh) |
ZA (1) | ZA201302822B (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2597159C2 (ru) * | 2010-11-12 | 2016-09-10 | Колгейт-Палмолив Компани | Продукт для ухода за полостью рта и способы его применения и изготовления |
MX370974B (es) * | 2014-10-24 | 2020-01-10 | Colgate Palmolive Co | Preparación de citrato de zinc y composiciones para cuidado oral que contienen citrato de zinc. |
BR102015027955B1 (pt) | 2014-11-11 | 2021-03-09 | Colgate-Palmolive Company | método de fabricação de uma composição para higiene bucal |
CN106999363B (zh) | 2014-12-12 | 2021-04-06 | 狮王株式会社 | 口腔用组合物 |
US10172786B2 (en) | 2014-12-16 | 2019-01-08 | Axim Biotechnologies, Inc. | Oral care composition comprising cannabinoids |
CA2971576A1 (en) * | 2014-12-26 | 2016-06-30 | Colgate-Palmolive Company | Zinc phosphate complex |
CA2971580C (en) * | 2014-12-26 | 2022-01-11 | Colgate-Palmolive Company | Oral care compositions and methods of use |
CN107530238B (zh) | 2015-04-29 | 2021-05-04 | 高露洁-棕榄公司 | 口腔护理组合物 |
WO2017219339A1 (en) * | 2016-06-24 | 2017-12-28 | Colgate-Palmolive Company | Oral care compositions and methods of use |
RU2635992C1 (ru) * | 2016-10-10 | 2017-11-17 | Общество с ограниченной ответственностью "Институт термологии" | Газированный ополаскиватель полости рта |
GB201811065D0 (en) * | 2018-07-05 | 2018-08-22 | GlaxoSmithKline Consumer Healthcare UK IP Ltd | Novel composition |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3678154A (en) | 1968-07-01 | 1972-07-18 | Procter & Gamble | Oral compositions for calculus retardation |
US3535421A (en) | 1968-07-11 | 1970-10-20 | Procter & Gamble | Oral compositions for calculus retardation |
US4152418A (en) | 1970-04-01 | 1979-05-01 | Lever Brothers Company | Zinc and enzyme mouthwash and mouthwash concentrate for reducing dental plaque and calculus formation |
US3696191A (en) | 1970-11-10 | 1972-10-03 | Monsanto Co | Dental creams containing enzymes |
US4058595A (en) | 1971-10-13 | 1977-11-15 | Colgate-Palmolive Company | Stabilized toothpastes containing an enzyme |
US3991177A (en) | 1973-11-27 | 1976-11-09 | Colgate-Palmolive Company | Oral compositions containing dextranase |
US4138477A (en) * | 1976-05-28 | 1979-02-06 | Colgate Palmolive Company | Composition to control mouth odor |
US4160820A (en) * | 1977-11-28 | 1979-07-10 | General Mills, Inc. | Plaque inhibiting composition and method |
US4289755A (en) * | 1980-11-03 | 1981-09-15 | Richardson-Vicks Inc. | Stable mouthwash compositions containing zinc and fluoride compounds |
US4355022A (en) | 1981-07-01 | 1982-10-19 | Interon, Inc. | Method of dental treatment |
US4885155A (en) | 1982-06-22 | 1989-12-05 | The Procter & Gamble Company | Anticalculus compositions using pyrophosphate salt |
US5000939A (en) | 1984-06-12 | 1991-03-19 | Colgate-Palmolive Company | Dentifrice containing stabilized enzyme |
US4889712A (en) * | 1986-03-20 | 1989-12-26 | Colgate-Palmolive Company | Anticalculus oral composition |
JP2681081B2 (ja) * | 1986-08-13 | 1997-11-19 | 湧永製薬株式会社 | 知覚過敏用口腔洗浄組成物 |
US5188821A (en) * | 1987-01-30 | 1993-02-23 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition mouthwash or liquid dentifrice |
CH671879A5 (zh) | 1987-02-26 | 1989-10-13 | Nestle Sa | |
US4866161A (en) | 1987-08-24 | 1989-09-12 | University Of South Alabama | Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof which have a clustered block copolymer structure |
US4842847A (en) | 1987-12-21 | 1989-06-27 | The B. F. Goodrich Company | Dental calculus inhibiting compositions |
US5094844A (en) * | 1990-12-20 | 1992-03-10 | Colgate-Palmolive Company | Anticalculus oral composition |
CA2143037C (en) * | 1994-05-02 | 2002-04-30 | Atma Chaudhari | Alcohol free mouthwash |
US5589159A (en) | 1995-04-11 | 1996-12-31 | Block Drug Company Inc. | Dispersible particulate system for desensitizing teeth |
BR9608343A (pt) * | 1995-06-05 | 1999-01-05 | Whitehill Oral Tech Inc | Produto com base em ultramulsion para higiene oral |
US5891422A (en) * | 1996-10-10 | 1999-04-06 | Warner-Lambert Company | Antimicrobial composition containing a C3 -C6 alcohol |
US7645746B1 (en) * | 2000-11-13 | 2010-01-12 | The Procter & Gamble Company | Composition for reducing malodor impression on inanimate surfaces |
US7563461B2 (en) * | 2002-02-07 | 2009-07-21 | The Trustees Of Columbia University In The City Of New York | Zinc salt compositions for the prevention of dermal and mucosal irritation |
US6723305B2 (en) * | 2002-03-04 | 2004-04-20 | Colgate Palmolive Company | Anti-microbial breath freshening mouthrinse |
AU2005282572A1 (en) * | 2004-09-06 | 2006-03-16 | Dr. Reddy's Laboratories Ltd | Fibrate compounds having PPAR agonist activity |
US20060115440A1 (en) * | 2004-09-07 | 2006-06-01 | Arata Andrew B | Silver dihydrogen citrate compositions |
AU2006330508B2 (en) * | 2005-12-21 | 2010-02-25 | Colgate-Palmolive Company | Improved oral compositions comprising zinc citrate and/or tocopherol agents |
US9723842B2 (en) * | 2006-05-26 | 2017-08-08 | Arch Chemicals, Inc. | Isothiazolinone biocides enhanced by zinc ions |
US8828363B2 (en) * | 2007-08-03 | 2014-09-09 | Gary H. EIREW | Pharmaceutical composition for improving oral hygiene and methods thereof |
ITTO20070857A1 (it) * | 2007-11-28 | 2009-05-29 | Cristina Capelli | Composizione conservante, metodo per la sua preparazione, suo uso e sua formulazione |
WO2009094198A1 (en) * | 2008-01-25 | 2009-07-30 | Mcintyre Group, Ltd. | Liquid preservative compositions |
CN101938979B (zh) * | 2008-02-08 | 2014-11-26 | 高露洁-棕榄公司 | 口腔护理方案 |
CN101938978A (zh) * | 2008-02-08 | 2011-01-05 | 高露洁-棕榄公司 | 口腔护理产品及其使用和制造方法 |
RU2597159C2 (ru) * | 2010-11-12 | 2016-09-10 | Колгейт-Палмолив Компани | Продукт для ухода за полостью рта и способы его применения и изготовления |
-
2010
- 2010-11-12 RU RU2013126518/15A patent/RU2597159C2/ru active
- 2010-11-12 US US13/884,035 patent/US20130230469A1/en not_active Abandoned
- 2010-11-12 CA CA2815640A patent/CA2815640C/en not_active Expired - Fee Related
- 2010-11-12 EP EP10779424.0A patent/EP2637633B1/en active Active
- 2010-11-12 SG SG2013026539A patent/SG189862A1/en unknown
- 2010-11-12 CN CN201710236079.1A patent/CN107252396A/zh active Pending
- 2010-11-12 BR BR112013011562A patent/BR112013011562C8/pt not_active IP Right Cessation
- 2010-11-12 PH PH1/2013/500721A patent/PH12013500721A1/en unknown
- 2010-11-12 JP JP2013536591A patent/JP2013540813A/ja active Pending
- 2010-11-12 MX MX2013005170A patent/MX338600B/es active IP Right Grant
- 2010-11-12 CN CN201710300880.8A patent/CN107432832A/zh active Pending
- 2010-11-12 CN CN201080070086.5A patent/CN103189040B/zh not_active Expired - Fee Related
- 2010-11-12 AU AU2010363659A patent/AU2010363659B2/en not_active Ceased
- 2010-11-12 WO PCT/US2010/056518 patent/WO2012064341A1/en active Application Filing
-
2011
- 2011-11-11 TW TW103129282A patent/TW201521772A/zh unknown
- 2011-11-11 TW TW100141169A patent/TWI533889B/zh not_active IP Right Cessation
- 2011-11-11 AR ARP110104240A patent/AR083864A1/es unknown
-
2013
- 2013-04-18 ZA ZA2013/02822A patent/ZA201302822B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2815640A1 (en) | 2012-05-18 |
ZA201302822B (en) | 2016-11-30 |
JP2013540813A (ja) | 2013-11-07 |
MX338600B (es) | 2016-04-22 |
CN103189040A (zh) | 2013-07-03 |
US20130230469A1 (en) | 2013-09-05 |
BR112013011562A2 (pt) | 2016-07-12 |
AU2010363659A1 (en) | 2013-05-02 |
EP2637633B1 (en) | 2018-07-11 |
WO2012064341A1 (en) | 2012-05-18 |
RU2013126518A (ru) | 2014-12-20 |
PH12013500721A1 (en) | 2013-05-20 |
RU2597159C2 (ru) | 2016-09-10 |
BR112013011562C8 (pt) | 2019-04-24 |
BR112013011562B8 (pt) | 2019-03-19 |
CN107432832A (zh) | 2017-12-05 |
MX2013005170A (es) | 2013-07-05 |
AR083864A1 (es) | 2013-03-27 |
CA2815640C (en) | 2016-06-14 |
TWI533889B (zh) | 2016-05-21 |
CN103189040B (zh) | 2017-05-31 |
TW201521772A (zh) | 2015-06-16 |
AU2010363659B2 (en) | 2015-09-17 |
SG189862A1 (en) | 2013-06-28 |
CN107252396A (zh) | 2017-10-17 |
EP2637633A1 (en) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201235053A (en) | Oral care product and methods of use and manufacture thereof | |
RU2700938C2 (ru) | Композиции для ухода за полостью рта и способы их применения | |
RU2325899C2 (ru) | Композиции для ухода за полостью рта, содержащие четвертичные аммониевые антимикробные реагенты с повышенными уровнями биологической доступности | |
RU2563990C2 (ru) | Продукт для ухода за полостью рта и способы его применения и получения | |
CA2706516C (en) | Cleaning compositions and methods | |
TW200946134A (en) | Oral care product and methods of use thereof | |
TW201330870A (zh) | 口腔保健組成物 | |
WO2025093061A1 (zh) | 一种用于封堵牙本质小管的络合物和治疗牙本质过敏的试剂及其应用 | |
CN116600770A (zh) | 具有氟化胺的口腔护理组合物 | |
CN113260352A (zh) | 口腔护理组合物及使用方法 | |
JP2016006102A (ja) | 口腔ケア製品およびその使用方法および製造方法 | |
CN119384265A (zh) | 口腔组合物和相关方法 | |
CN118401228A (zh) | 口腔护理组合物及使用方法 | |
BR112013011562B1 (pt) | Ornamental and cosmetic method for improving oral health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |